Literature DB >> 25479872

Reconstruction and analysis of correlation networks based on GC-MS metabolomics data for young hypertensive men.

Le Wang1, Entai Hou1, Lijun Wang2, Yanjun Wang3, Lingjian Yang4, Xiaohui Zheng4, Guangqi Xie1, Qiong Sun1, Mingyu Liang5, Zhongmin Tian6.   

Abstract

The awareness, treatment, and control rates of hypertension for young adults are much lower than average. It is urgently needed to explore the variances of metabolic profiles for early diagnosis and treatment of hypertension. In current study, we applied a GC-MS based metabolomics platform coupled with a network approach to analyze plasma samples from young hypertensive men and age-matched healthy controls. Our findings confirmed distinct metabolic footprints of young hypertensive men. The significantly altered metabolites between two groups were enriched for the biological module of amino acids biosynthesis. The correlations of GC-MS metabolomics data were then visualized as networks based on Pearson correlation coefficient (threshold=0.6). The plasma metabolites identified by GC-MS and the significantly altered metabolites (P<0.05) between patients and controls were respectively included as nodes of a network. Statistical and topological characteristics of the networks were studied in detail. A few amino acids, glycine, lysine, and cystine, were screened as hub metabolites with higher values of degree (k), and also obtained highest scores of three centrality indices. The short average path lengths and high clustering coefficients of the networks revealed a small-world property, indicating that variances of these amino acids have a major impact on the metabolic change in young hypertensive men. These results suggested that disorders of amino acid metabolism might play an important role in predisposing young men to developing hypertension. The combination of metabolomics and network methods would provide another perspective on expounding the molecular mechanism underlying complex diseases.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Centrality indices; Correlation network; GC–MS; Hub metabolites; Hypertension; Metabolomics

Mesh:

Substances:

Year:  2014        PMID: 25479872      PMCID: PMC4432937          DOI: 10.1016/j.aca.2014.11.009

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  70 in total

Review 1.  Network biology: understanding the cell's functional organization.

Authors:  Albert-László Barabási; Zoltán N Oltvai
Journal:  Nat Rev Genet       Date:  2004-02       Impact factor: 53.242

2.  Paper spray ionization of polar analytes using non-polar solvents.

Authors:  Anyin Li; He Wang; Zheng Ouyang; R Graham Cooks
Journal:  Chem Commun (Camb)       Date:  2011-02-01       Impact factor: 6.222

3.  Metabolic profiling of serum using Ultra Performance Liquid Chromatography and the LTQ-Orbitrap mass spectrometry system.

Authors:  Warwick B Dunn; David Broadhurst; Marie Brown; Philip N Baker; Christopher W G Redman; Louise C Kenny; Douglas B Kell
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-04-01       Impact factor: 3.205

4.  Dietary amino acids and blood pressure: a cohort study of patients with cardiovascular disease.

Authors:  Katherine R Tuttle; Joan E Milton; Diane P Packard; Lynn A Shuler; Robert A Short
Journal:  Am J Kidney Dis       Date:  2012-03-03       Impact factor: 8.860

Review 5.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

6.  Mass spectrometry sequencing of transfer ribonucleic acids by the comparative analysis of RNA digests (CARD) approach.

Authors:  Siwei Li; Patrick A Limbach
Journal:  Analyst       Date:  2013-03-07       Impact factor: 4.616

7.  Association between protein intake and blood pressure: the INTERMAP Study.

Authors:  Paul Elliott; Jeremiah Stamler; Alan R Dyer; Lawrence Appel; Barbara Dennis; Hugo Kesteloot; Hirotsugu Ueshima; Akira Okayama; Queenie Chan; Daniel B Garside; Beifan Zhou
Journal:  Arch Intern Med       Date:  2006-01-09

8.  Recent highlights of metabolomics in cardiovascular research.

Authors:  Manuel Mayr
Journal:  Circ Cardiovasc Genet       Date:  2011-08-01

9.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 10.  Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.

Authors:  Richard J Johnson; Mark S Segal; Yuri Sautin; Takahiko Nakagawa; Daniel I Feig; Duk-Hee Kang; Michael S Gersch; Steven Benner; Laura G Sánchez-Lozada
Journal:  Am J Clin Nutr       Date:  2007-10       Impact factor: 7.045

View more
  23 in total

1.  GC-MS metabolic profiling reveals fructose-2,6-bisphosphate regulates branched chain amino acid metabolism in the heart during fasting.

Authors:  Albert Batushansky; Satoshi Matsuzaki; Maria F Newhardt; Melinda S West; Timothy M Griffin; Kenneth M Humphries
Journal:  Metabolomics       Date:  2019-01-28       Impact factor: 4.290

2.  Elevation of fumarase attenuates hypertension and can result from a nonsynonymous sequence variation or increased expression depending on rat strain.

Authors:  Kristie Usa; Yong Liu; Aron M Geurts; Yuan Cheng; Jozef Lazar; Maria Angeles Baker; Michael Grzybowski; Yongcheng He; Zhongmin Tian; Mingyu Liang
Journal:  Physiol Genomics       Date:  2017-07-28       Impact factor: 3.107

3.  Serum metabolites of hypertension among Chinese adolescents aged 12-17 years.

Authors:  Jiahong Sun; Wenqing Ding; Xue Liu; Min Zhao; Bo Xi
Journal:  J Hum Hypertens       Date:  2021-09-03       Impact factor: 2.877

Review 4.  Genomic Determinants of Hypertension With a Focus on Metabolomics and the Gut Microbiome.

Authors:  Panayiotis Louca; Cristina Menni; Sandosh Padmanabhan
Journal:  Am J Hypertens       Date:  2020-05-21       Impact factor: 2.689

5.  Applications of Chromatography-Ultra High-Resolution MS for Stable Isotope-Resolved Metabolomics (SIRM) Reconstruction of Metabolic Networks.

Authors:  Qiushi Sun; Teresa W-M Fan; Andrew N Lane; Richard M Higashi
Journal:  Trends Analyt Chem       Date:  2019-10-01       Impact factor: 12.296

6.  A Computational Method of Defining Potential Biomarkers based on Differential Sub-Networks.

Authors:  Xin Huang; Xiaohui Lin; Jun Zeng; Lichao Wang; Peiyuan Yin; Lina Zhou; Chunxiu Hu; Weihong Yao
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

7.  Gas chromatography-time of flight/mass spectrometry-based metabonomics of changes in the urinary metabolic profile in osteoarthritic rats.

Authors:  Hui Jiang; Jian Liu; Xiu-Juan Qin; Yuan-Yuan Chen; Jia-Rong Gao; Mei Meng; Yuan Wang; Ting Wang
Journal:  Exp Ther Med       Date:  2018-01-24       Impact factor: 2.447

8.  Effects of Shu Gan Jian Pi formula on rats with carbon tetrachloride‑induced liver fibrosis using serum metabonomics based on gas chromatography‑time of flight mass spectrometry.

Authors:  Hui Jiang; Xiu-Juan Qin; Wei-Ping Li; Rong Ma; Ting Wang; Zhu-Qing Li
Journal:  Mol Med Rep       Date:  2017-07-24       Impact factor: 2.952

9.  An untargeted metabolomics study of blood pressure: findings from the Bogalusa Heart Study.

Authors:  William J He; Changwei Li; Xuenan Mi; Mengyao Shi; Xiaoying Gu; Lydia A Bazzano; Alexander C Razavi; Jovia L Nierenberg; Kirsten Dorans; Hua He; Tanika N Kelly
Journal:  J Hypertens       Date:  2020-07       Impact factor: 4.844

10.  Urinary Metabolites Associated with Blood Pressure on a Low- or High-Sodium Diet.

Authors:  Yuan Cheng; Haiying Song; Xiaoqing Pan; Hong Xue; Yifei Wan; Tao Wang; Zhongmin Tian; Entai Hou; Ian R Lanza; Pengyuan Liu; Yong Liu; Purushottam W Laud; Kristie Usa; Yongcheng He; Mingyu Liang
Journal:  Theranostics       Date:  2018-02-05       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.